Senate Resolution No. by Senator Talbot urges the Louisiana Department of Insurance and the Louisiana Department of Health to conduct a comprehensive review of the implementation and enforcement of the state's biomarker testing coverage law, which mandates health insurance coverage for biomarker testing supported by medical evidence and clinical guidelines. The resolution highlights the importance of biomarker testing in the diagnosis and treatment of serious diseases, particularly cancer, and addresses concerns raised by stakeholders regarding access to testing, claims processing, and delays in approval that could negatively impact patient outcomes.

The resolution calls for a detailed report to be submitted to relevant legislative committees by February 1, 2027, outlining various aspects of biomarker testing claims, including the number of claims submitted, approval and denial rates, reasons for denials, and the average time taken for testing. It also seeks to identify barriers to patient access and provide recommendations for legislative or regulatory changes to improve compliance and transparency. The Departments are encouraged to consult with stakeholders throughout the review process to ensure a comprehensive understanding of the issues at hand.